WASHINGTON — A federal judge on Monday blocked a Trump administration regulation that requires drug makers to include their sticker prices in ads.
The decision, which came just hours before the rule was set to take effect at midnight on Wednesday, came after three major drug makers sued the administration in June, arguing the Department of Health and Human Services did not have the authority to require these disclosures and that requiring them violated the drug makers’ First Amendment rights.
Judge Amit Mehta of the D.C. District Court found that HHS had overstepped its authority in requiring such disclosures. However, he did not rule on the drug makers’ First Amendment concerns.
This article is exclusive to STAT+ subscribers
Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.
Already have an account? Log in
Already have an account? Log in
About the Author Reprints
To submit a correction request, please visit our Contact Us page.
STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect